Group 1 agent | Other sites with limited evidence in humans |
Epstein-Barr virus (EBV) | Gastric carcinoma, lymphoepithelioma-like carcinoma |
Kaposi sarcoma herpesvirus (KSHV) | Multicentric castleman's disease |
Human Papillomavirus type 16 (HPV-16) | Cancer of the larynx |